RIKER LAUREN
Senior Vice President, Finance
Sale 10b5-1
- Shares
- 6,000
- Price
- $36.32
- Value
- $217,920
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•44 filings
PCRX
Pacira BioSciences, Inc.
Net sales of $288.5K over the last 3 months
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$288,539
0 buyers · 2 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,750,044
5 distinct insiders
Highlighted alerts
2
17 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get PCRX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PCRX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
70
Raw transactions
Everything returned by the filing
19
Voluntary view
P/S trades after deterministic checks
51
Administrative noise
Stored, never alerted
35
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- M
- Shares
- 6,000
- Price
- $32.35
- Footnotes
- 2
The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026. The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.
Raspberry interpretation
Informational — no alert
Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
SLONIN JONATHAN
Chief Medical Officer
Sale 10b5-1
- Shares
- 3,040
- Price
- $23.23
- Value
- $70,619
RIKER LAUREN
Senior Vice President, Finance
Sale 10b5-1
- Shares
- 6,115
- Price
- $23.50
- Value
- $143,703
WILLIAMS KRISTEN
Chief Administrative Officer
Sale 10b5-1
- Shares
- 10,259
- Price
- $22.27
- Value
- $228,468
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 12,941
- Price
- $25.16
- Value
- $325,596
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 1,500
- Price
- $25.01
- Value
- $37,515
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 2,845
- Price
- $25.01
- Value
- $71,153
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 7,714
- Price
- $25.14
- Value
- $193,930
SLONIN JONATHAN
Chief Medical Officer
Sale 10b5-1
- Shares
- 3,261
- Price
- $22.82
- Value
- $74,416
Froimson Mark
Director
SaleAlert
- Shares
- 500
- Price
- $21.81
- Value
- $10,905
RIKER LAUREN
Senior Vice President, Finance
Sale 10b5-1
- Shares
- 4,000
- Price
- $20.81
- Value
- $83,240
WILLIAMS KRISTEN
Chief Administrative Officer
Sale 10b5-1
- Shares
- 13,137
- Price
- $20.53
- Value
- $269,703
RIKER LAUREN
Senior Vice President, Finance
Sale 10b5-1
- Shares
- 1,416
- Price
- $24.24
- Value
- $34,324
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 9,104
- Price
- $25.14
- Value
- $228,875
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 15,896
- Price
- $25.03
- Value
- $397,877
SLONIN JONATHAN
Chief Medical Officer
Sale 10b5-1
- Shares
- 3,960
- Price
- $24.09
- Value
- $95,396
Cross Shawn
Chief Financial Officer
Sale 10b5-1
- Shares
- 12,060
- Price
- $22.09
- Value
- $266,405
Ceesay Abraham
Director
Sale 10b5-1
- Shares
- 2,354
- Price
- $27.19
- Value
- $64,005
BIGAL MARCELO
Director
SaleAlert
- Shares
- 4,912
- Price
- $23.67
- Value
- $116,267
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 08, 2026 | RIKER LAUREN Senior Vice President, Finance | Sale | 6,000 | $36.32 | $217,920 | |
| Aug 17, 2026 | SLONIN JONATHAN Chief Medical Officer | Sale | 3,040 | $23.23 | $70,619 | |
| Jun 11, 2026 | RIKER LAUREN Senior Vice President, Finance | Sale | 6,115 | $23.50 | $143,703 | |
| Jun 04, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Sale | 10,259 | $22.27 | $228,468 | |
| Apr 23, 2026 | Cross Shawn Chief Financial Officer | Sale | 12,941 | $25.16 | $325,596 | |
| Apr 22, 2026 | Cross Shawn Chief Financial Officer | Sale | 1,500 | $25.01 | $37,515 | |
| Apr 21, 2026 | Cross Shawn Chief Financial Officer | Sale | 2,845 | $25.01 | $71,153 | |
| Apr 20, 2026 | Cross Shawn Chief Financial Officer | Sale | 7,714 | $25.14 | $193,930 | |
| Mar 17, 2026 | SLONIN JONATHAN Chief Medical Officer | Sale | 3,261 | $22.82 | $74,416 | |
| Mar 17, 2026 | Froimson Mark Director | Sale | 500 | $21.81 | $10,905 | |
| Feb 02, 2026 | RIKER LAUREN Senior Vice President, Finance | Sale | 4,000 | $20.81 | $83,240 | |
| Feb 02, 2026 | WILLIAMS KRISTEN Chief Administrative Officer | Sale | 13,137 | $20.53 | $269,703 | |
| Jan 05, 2026 | RIKER LAUREN Senior Vice President, Finance | Sale | 1,416 | $24.24 | $34,324 | |
| Dec 10, 2025 | Cross Shawn Chief Financial Officer | Sale | 9,104 | $25.14 | $228,875 | |
| Dec 09, 2025 | Cross Shawn Chief Financial Officer | Sale | 15,896 | $25.03 | $397,877 | |
| Nov 17, 2025 | SLONIN JONATHAN Chief Medical Officer | Sale | 3,960 | $24.09 | $95,396 | |
| Nov 10, 2025 | Cross Shawn Chief Financial Officer | Sale | 12,060 | $22.09 | $266,405 | |
| Sep 04, 2025 | Ceesay Abraham Director | Sale | 2,354 | $27.19 | $64,005 | |
| Aug 07, 2025 | BIGAL MARCELO Director | Sale | 4,912 | $23.67 | $116,267 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.